Audit 311963

FY End
2022-05-31
Total Expended
$3.74M
Findings
4
Programs
3
Organization: Madelia Health (MN)
Year: 2022 Accepted: 2023-02-27
Auditor: Eide Bailly LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
410380 2022-004 Material Weakness - AB
410381 2022-004 Material Weakness - L
986822 2022-004 Material Weakness - AB
986823 2022-004 Material Weakness - L

Programs

ALN Program Spent Major Findings
93.498 Provider Relief Fund $3.61M Yes 2
93.461 Covid-19 Testing for the Uninsured $117,623 - 0
93.301 Small Rural Hospital Improvement Grant Program $11,206 - 0

Contacts

Name Title Type
W9TCSLGWFV17 Bruce Craven Auditee
5076425204 Joy Feige Auditor
No contacts on file

Notes to SEFA

Title: Basis of Presentation Accounting Policies: Expenditures reported on the schedule are reported on the accrual basis of accounting, with the exception for the COVID-19 HRSA Claims Reimbursement for the Uninsured Program and the COVID-19 Coverage Assistance Fund, which are based on when the claim is determined eligible evidenced by the receipt of monies from the federal agency. When applicable, such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. No federal financial assistance has been provided to a subrecipient. De Minimis Rate Used: N Rate Explanation: The Hospital has not elected to use the 10% de minimis cost rate. The accompanying consolidated schedule of expenditures of federal awards (the schedule) includes the federal award activity of Madelia Health and Madelia Health Foundation which are referred to as Madelia Health and Affiliate (collectively, the Hospital) under programs of the federal government for the year ended May 31, 2022. The information is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the schedule presents only a selected portion of the operations of the Hospital, it is not intended to and does not present the financial position, changes in net assets, or cash flows of the Hospital.
Title: Provider Relief Fund and American Rescue Plan Rural Distribution Accounting Policies: Expenditures reported on the schedule are reported on the accrual basis of accounting, with the exception for the COVID-19 HRSA Claims Reimbursement for the Uninsured Program and the COVID-19 Coverage Assistance Fund, which are based on when the claim is determined eligible evidenced by the receipt of monies from the federal agency. When applicable, such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. No federal financial assistance has been provided to a subrecipient. De Minimis Rate Used: N Rate Explanation: The Hospital has not elected to use the 10% de minimis cost rate. The Hospital received amounts from the U.S. Department of Health and Human Services (HHS) through the Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution (PRF) program (Federal Financial Assistance Listing #93.498) during the year ended May 31, 2020 as it relates to Period 1 funds. The PRF expenditures were not recognized on the schedule until the expenditures were included in the reporting to HHS for the funds received prior to June 30, 2020 (Period 1), as required under the PRF program. The following summarizes the Provider Relief Funds and the timing of when the amounts were recognized in the consolidated financial statements. (see table in report)The Hospital reported $245,995 of unrealized gains on investments in error as interest earned on other PRF payments within the Hospitals Special Report submitted to the Department of Health and Human Services (HHS) for Period 1 TIN #410758512. The unrealized gains on investments plus $3,614,717 for funds received totals $3,860,712, which is the total reportable PRF payments included within the Hospitals Special Report submitted to HHS for Period 1. During the year ended May 31, 2022, the Hospital received additional amounts totaling $260,257 from HHS through the PRF program which were reported as a refundable advance on the consolidated financial statements for the year ended May 31, 2022. These funds will not be recognized on the schedule until they are included in the reporting to HHS for Period 4.

Finding Details

2022-004 Department of Health and Human ServicesFederal Financial Assistance Listing #93.498COVID-19 Provider Relief Fund and American Rescue Plan (ARP) Rural DistributionApplicable Federal Award Number and Year ? Period 1 TIN #410758512Activities Allowed or Unallowed and Allowable Costs/Cost PrinciplesMaterial Weakness in Internal Control over Compliance and NoncomplianceReportingMaterial Weakness in Internal Control over Compliance and Material NoncomplianceCriteria: 2 CRF 200.303(a) establishes that the auditee must establish and maintain effective internal control over the federal award that provides assurance that the entity is managing the federal award in compliance with federal statutes, regulations, and conditions of the federal award.Condition: During testing we identified the following:- No formal documentation of review and approval of the Hospital?s final expenditures listing identified as eligible and claimed under the Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution program (the program) was retained.- Payroll reports to support the COVID-related bonuses based on hours worked were not retained and were not able to be recreated.- Some expenses claimed under the program were incurred before the Hospital started preparing, preventing, and responding to COVID. Net costs of $36,540.- Equipment and information technology expenses claimed under other sources of funding were claimed under the program. Net actual costs of $6,080.- Utility expenses and personnel expenses were overclaimed under the program based on a review of supporting documentation. Net costs of $2,985 with projected net costs of $3,827.- No formal documentation of review and approval of the Hospital?s lost revenue calculation and the Hospital?s special report submitted to HHS for Period 1 TIN #410758512 was retained.- The lost revenue narrative to describe the option iii calculation did not agree with the supporting calculation performed for January and February 2021. The narrative indicated a comparison to January and February of 2019, but the calculation was done based on January and February 2020 trended revenue.- Expenses claimed under the program and included within the Hospital?s special report submitted to the Department of Health and Human Services (HHS) for Period 1 TIN #410758512 were reported at gross cost and did not consider the Hospital?s Medicare Cost Reimbursement percentage. Net costs of $880,880.Cause: Management did not retain documentation of the review and approval of the final expenditures listing, lost revenue calculation, and the special report submitted to HHS for Period 1 TIN #410758512. When preparing the final expenditures listing, management claimed expenses which were incurred prior to the Hospital preparing, preventing, and responding to COVID and management overlooked two expenses being claimed under other funding sources. Utility expenses and personnel expenses were overclaimed based upon review of supporting documentation. When completing the special report submitted to HHS for Period 1 TIN #410758512, management claimed expenses at gross and reported the same expenses net of Medicare reimbursement within the unreimbursed section of the special report.Effect: Without a secondary review and approval, there is a possibility that ineligible expenditures are claimed under the program and included within the special report and the lost revenue calculation may not be calculated in accordance with the terms and conditions of the program. Expenses included within the special report submitted to HHS for Period 1 TIN #410758512 were overstated by net costs of $926,485.Questioned Costs: As reported in Period 1, the Hospital has additional lost revenue that exceeds the expenses identified during testing. As a result, there are no questioned costs for activities allowed or unallowed and allowable costs/cost principles. Expenses included within the special report submitted to HHS for Period 1 were overstated by net costs of $926,485.Context: A nonstatistical sample of 60 ($82,114) out of a population greater than 250 transactions relating to general and administrative and healthcare related expenses, including personnel, fringe benefits, supplies, equipment, and information technology ($143,368) were tested. Summary level testing was performed over general and administrative and healthcare related expenses, including mortgage, insurance, utilities, personnel, and facilities. Key line items were tested on the Period 1 Department of Health and Human Services special report.Repeat Finding from Prior Years: NoRecommendation: We recommend management retain formal documentation of review and approval process of the final expenditures listing, lost revenue and special reports submitted to the federal agency. In addition, we recommend management update any future special reports submitted to the Department of Health and Human Services as deemed appropriate.Views of Responsible Officials: Management agrees with the finding.
2022-004 Department of Health and Human ServicesFederal Financial Assistance Listing #93.498COVID-19 Provider Relief Fund and American Rescue Plan (ARP) Rural DistributionApplicable Federal Award Number and Year ? Period 1 TIN #410758512Activities Allowed or Unallowed and Allowable Costs/Cost PrinciplesMaterial Weakness in Internal Control over Compliance and NoncomplianceReportingMaterial Weakness in Internal Control over Compliance and Material NoncomplianceCriteria: 2 CRF 200.303(a) establishes that the auditee must establish and maintain effective internal control over the federal award that provides assurance that the entity is managing the federal award in compliance with federal statutes, regulations, and conditions of the federal award.Condition: During testing we identified the following:- No formal documentation of review and approval of the Hospital?s final expenditures listing identified as eligible and claimed under the Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution program (the program) was retained.- Payroll reports to support the COVID-related bonuses based on hours worked were not retained and were not able to be recreated.- Some expenses claimed under the program were incurred before the Hospital started preparing, preventing, and responding to COVID. Net costs of $36,540.- Equipment and information technology expenses claimed under other sources of funding were claimed under the program. Net actual costs of $6,080.- Utility expenses and personnel expenses were overclaimed under the program based on a review of supporting documentation. Net costs of $2,985 with projected net costs of $3,827.- No formal documentation of review and approval of the Hospital?s lost revenue calculation and the Hospital?s special report submitted to HHS for Period 1 TIN #410758512 was retained.- The lost revenue narrative to describe the option iii calculation did not agree with the supporting calculation performed for January and February 2021. The narrative indicated a comparison to January and February of 2019, but the calculation was done based on January and February 2020 trended revenue.- Expenses claimed under the program and included within the Hospital?s special report submitted to the Department of Health and Human Services (HHS) for Period 1 TIN #410758512 were reported at gross cost and did not consider the Hospital?s Medicare Cost Reimbursement percentage. Net costs of $880,880.Cause: Management did not retain documentation of the review and approval of the final expenditures listing, lost revenue calculation, and the special report submitted to HHS for Period 1 TIN #410758512. When preparing the final expenditures listing, management claimed expenses which were incurred prior to the Hospital preparing, preventing, and responding to COVID and management overlooked two expenses being claimed under other funding sources. Utility expenses and personnel expenses were overclaimed based upon review of supporting documentation. When completing the special report submitted to HHS for Period 1 TIN #410758512, management claimed expenses at gross and reported the same expenses net of Medicare reimbursement within the unreimbursed section of the special report.Effect: Without a secondary review and approval, there is a possibility that ineligible expenditures are claimed under the program and included within the special report and the lost revenue calculation may not be calculated in accordance with the terms and conditions of the program. Expenses included within the special report submitted to HHS for Period 1 TIN #410758512 were overstated by net costs of $926,485.Questioned Costs: As reported in Period 1, the Hospital has additional lost revenue that exceeds the expenses identified during testing. As a result, there are no questioned costs for activities allowed or unallowed and allowable costs/cost principles. Expenses included within the special report submitted to HHS for Period 1 were overstated by net costs of $926,485.Context: A nonstatistical sample of 60 ($82,114) out of a population greater than 250 transactions relating to general and administrative and healthcare related expenses, including personnel, fringe benefits, supplies, equipment, and information technology ($143,368) were tested. Summary level testing was performed over general and administrative and healthcare related expenses, including mortgage, insurance, utilities, personnel, and facilities. Key line items were tested on the Period 1 Department of Health and Human Services special report.Repeat Finding from Prior Years: NoRecommendation: We recommend management retain formal documentation of review and approval process of the final expenditures listing, lost revenue and special reports submitted to the federal agency. In addition, we recommend management update any future special reports submitted to the Department of Health and Human Services as deemed appropriate.Views of Responsible Officials: Management agrees with the finding.
2022-004 Department of Health and Human ServicesFederal Financial Assistance Listing #93.498COVID-19 Provider Relief Fund and American Rescue Plan (ARP) Rural DistributionApplicable Federal Award Number and Year ? Period 1 TIN #410758512Activities Allowed or Unallowed and Allowable Costs/Cost PrinciplesMaterial Weakness in Internal Control over Compliance and NoncomplianceReportingMaterial Weakness in Internal Control over Compliance and Material NoncomplianceCriteria: 2 CRF 200.303(a) establishes that the auditee must establish and maintain effective internal control over the federal award that provides assurance that the entity is managing the federal award in compliance with federal statutes, regulations, and conditions of the federal award.Condition: During testing we identified the following:- No formal documentation of review and approval of the Hospital?s final expenditures listing identified as eligible and claimed under the Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution program (the program) was retained.- Payroll reports to support the COVID-related bonuses based on hours worked were not retained and were not able to be recreated.- Some expenses claimed under the program were incurred before the Hospital started preparing, preventing, and responding to COVID. Net costs of $36,540.- Equipment and information technology expenses claimed under other sources of funding were claimed under the program. Net actual costs of $6,080.- Utility expenses and personnel expenses were overclaimed under the program based on a review of supporting documentation. Net costs of $2,985 with projected net costs of $3,827.- No formal documentation of review and approval of the Hospital?s lost revenue calculation and the Hospital?s special report submitted to HHS for Period 1 TIN #410758512 was retained.- The lost revenue narrative to describe the option iii calculation did not agree with the supporting calculation performed for January and February 2021. The narrative indicated a comparison to January and February of 2019, but the calculation was done based on January and February 2020 trended revenue.- Expenses claimed under the program and included within the Hospital?s special report submitted to the Department of Health and Human Services (HHS) for Period 1 TIN #410758512 were reported at gross cost and did not consider the Hospital?s Medicare Cost Reimbursement percentage. Net costs of $880,880.Cause: Management did not retain documentation of the review and approval of the final expenditures listing, lost revenue calculation, and the special report submitted to HHS for Period 1 TIN #410758512. When preparing the final expenditures listing, management claimed expenses which were incurred prior to the Hospital preparing, preventing, and responding to COVID and management overlooked two expenses being claimed under other funding sources. Utility expenses and personnel expenses were overclaimed based upon review of supporting documentation. When completing the special report submitted to HHS for Period 1 TIN #410758512, management claimed expenses at gross and reported the same expenses net of Medicare reimbursement within the unreimbursed section of the special report.Effect: Without a secondary review and approval, there is a possibility that ineligible expenditures are claimed under the program and included within the special report and the lost revenue calculation may not be calculated in accordance with the terms and conditions of the program. Expenses included within the special report submitted to HHS for Period 1 TIN #410758512 were overstated by net costs of $926,485.Questioned Costs: As reported in Period 1, the Hospital has additional lost revenue that exceeds the expenses identified during testing. As a result, there are no questioned costs for activities allowed or unallowed and allowable costs/cost principles. Expenses included within the special report submitted to HHS for Period 1 were overstated by net costs of $926,485.Context: A nonstatistical sample of 60 ($82,114) out of a population greater than 250 transactions relating to general and administrative and healthcare related expenses, including personnel, fringe benefits, supplies, equipment, and information technology ($143,368) were tested. Summary level testing was performed over general and administrative and healthcare related expenses, including mortgage, insurance, utilities, personnel, and facilities. Key line items were tested on the Period 1 Department of Health and Human Services special report.Repeat Finding from Prior Years: NoRecommendation: We recommend management retain formal documentation of review and approval process of the final expenditures listing, lost revenue and special reports submitted to the federal agency. In addition, we recommend management update any future special reports submitted to the Department of Health and Human Services as deemed appropriate.Views of Responsible Officials: Management agrees with the finding.
2022-004 Department of Health and Human ServicesFederal Financial Assistance Listing #93.498COVID-19 Provider Relief Fund and American Rescue Plan (ARP) Rural DistributionApplicable Federal Award Number and Year ? Period 1 TIN #410758512Activities Allowed or Unallowed and Allowable Costs/Cost PrinciplesMaterial Weakness in Internal Control over Compliance and NoncomplianceReportingMaterial Weakness in Internal Control over Compliance and Material NoncomplianceCriteria: 2 CRF 200.303(a) establishes that the auditee must establish and maintain effective internal control over the federal award that provides assurance that the entity is managing the federal award in compliance with federal statutes, regulations, and conditions of the federal award.Condition: During testing we identified the following:- No formal documentation of review and approval of the Hospital?s final expenditures listing identified as eligible and claimed under the Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution program (the program) was retained.- Payroll reports to support the COVID-related bonuses based on hours worked were not retained and were not able to be recreated.- Some expenses claimed under the program were incurred before the Hospital started preparing, preventing, and responding to COVID. Net costs of $36,540.- Equipment and information technology expenses claimed under other sources of funding were claimed under the program. Net actual costs of $6,080.- Utility expenses and personnel expenses were overclaimed under the program based on a review of supporting documentation. Net costs of $2,985 with projected net costs of $3,827.- No formal documentation of review and approval of the Hospital?s lost revenue calculation and the Hospital?s special report submitted to HHS for Period 1 TIN #410758512 was retained.- The lost revenue narrative to describe the option iii calculation did not agree with the supporting calculation performed for January and February 2021. The narrative indicated a comparison to January and February of 2019, but the calculation was done based on January and February 2020 trended revenue.- Expenses claimed under the program and included within the Hospital?s special report submitted to the Department of Health and Human Services (HHS) for Period 1 TIN #410758512 were reported at gross cost and did not consider the Hospital?s Medicare Cost Reimbursement percentage. Net costs of $880,880.Cause: Management did not retain documentation of the review and approval of the final expenditures listing, lost revenue calculation, and the special report submitted to HHS for Period 1 TIN #410758512. When preparing the final expenditures listing, management claimed expenses which were incurred prior to the Hospital preparing, preventing, and responding to COVID and management overlooked two expenses being claimed under other funding sources. Utility expenses and personnel expenses were overclaimed based upon review of supporting documentation. When completing the special report submitted to HHS for Period 1 TIN #410758512, management claimed expenses at gross and reported the same expenses net of Medicare reimbursement within the unreimbursed section of the special report.Effect: Without a secondary review and approval, there is a possibility that ineligible expenditures are claimed under the program and included within the special report and the lost revenue calculation may not be calculated in accordance with the terms and conditions of the program. Expenses included within the special report submitted to HHS for Period 1 TIN #410758512 were overstated by net costs of $926,485.Questioned Costs: As reported in Period 1, the Hospital has additional lost revenue that exceeds the expenses identified during testing. As a result, there are no questioned costs for activities allowed or unallowed and allowable costs/cost principles. Expenses included within the special report submitted to HHS for Period 1 were overstated by net costs of $926,485.Context: A nonstatistical sample of 60 ($82,114) out of a population greater than 250 transactions relating to general and administrative and healthcare related expenses, including personnel, fringe benefits, supplies, equipment, and information technology ($143,368) were tested. Summary level testing was performed over general and administrative and healthcare related expenses, including mortgage, insurance, utilities, personnel, and facilities. Key line items were tested on the Period 1 Department of Health and Human Services special report.Repeat Finding from Prior Years: NoRecommendation: We recommend management retain formal documentation of review and approval process of the final expenditures listing, lost revenue and special reports submitted to the federal agency. In addition, we recommend management update any future special reports submitted to the Department of Health and Human Services as deemed appropriate.Views of Responsible Officials: Management agrees with the finding.